Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arie R Gafson

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Multiple Sclerosis and Related Disorders|April 17, 2015
CCSVI-A. A call to clinicans and scientists to vocalise in an Internet ageArie R Gafson, Gavin Giovannoni
BMJ Case Reports|July 14, 2012
Observations and hypothesis on an individual patient topically treated for capecitabine-induced Palmar-Plantar syndromeArie R Gafson, Olivia Goodkin, Richard Begent
Plos One|January 13, 2017
Inflammatory Activity on Natalizumab Predicts Short-Term but Not Long-Term Disability in Multiple SclerosisJoel Raffel, Arie R Gafson, Samer Dahdaleh, et al.
Frontiers in Neurology|July 31, 2018
Remote Monitoring in the Home Validates Clinical Gait Measures for Multiple SclerosisAkara Supratak, Gourab Datta, Arie R Gafson, et al.
Frontiers in Cellular Neuroscience|August 20, 2024
New views on the complex interplay between degeneration and autoimmunity in multiple sclerosisPeter K Stys, Shigeki Tsutsui, Arie R Gafson, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|October 5, 2018
Mononuclear cell transcriptome changes associated with dimethyl fumarate in MSArie R Gafson, Kicheol Kim, Maria T Cencioni, et al.
Multiple Sclerosis and Related Disorders|July 17, 2023
Assessing the utility of magnetic resonance imaging-based "SuStaIn" disease subtyping for precision medicine in relapsing-remitting and secondary progressive multiple sclerosisXiaotong Jiang, Changyu Shen, Bastien Caba, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|May 16, 2019
Breaking the cycle: Reversal of flux in the tricarboxylic acid cycle by dimethyl fumarateArie R Gafson, Constantinos Savva, Tom Thorne, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 6, 2021
A randomized study of natalizumab dosing regimens for relapsing-remitting multiple sclerosisMaria Trojano, Lluís Ramió-Torrentà, Luigi Me Grimaldi, et al.
CNS Drugs|July 29, 2021
Safety, Patient-Reported Well-Being, and Physician-Reported Assessment of Walking Ability in Patients with Multiple Sclerosis for Prolonged-Release Fampridine Treatment in Routine Clinical Practice: Results of the LIBERATE StudyGiovanni Castelnovo, Oliver Gerlach, Mark S Freedman, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Multiple Sclerosis and Related Disorders|April 17, 2015
CCSVI-A. A call to clinicans and scientists to vocalise in an Internet ageArie R Gafson, Gavin Giovannoni
BMJ Case Reports|July 14, 2012
Observations and hypothesis on an individual patient topically treated for capecitabine-induced Palmar-Plantar syndromeArie R Gafson, Olivia Goodkin, Richard Begent
Plos One|January 13, 2017
Inflammatory Activity on Natalizumab Predicts Short-Term but Not Long-Term Disability in Multiple SclerosisJoel Raffel, Arie R Gafson, Samer Dahdaleh, et al.
Frontiers in Neurology|July 31, 2018
Remote Monitoring in the Home Validates Clinical Gait Measures for Multiple SclerosisAkara Supratak, Gourab Datta, Arie R Gafson, et al.
Frontiers in Cellular Neuroscience|August 20, 2024
New views on the complex interplay between degeneration and autoimmunity in multiple sclerosisPeter K Stys, Shigeki Tsutsui, Arie R Gafson, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|October 5, 2018
Mononuclear cell transcriptome changes associated with dimethyl fumarate in MSArie R Gafson, Kicheol Kim, Maria T Cencioni, et al.
Multiple Sclerosis and Related Disorders|July 17, 2023
Assessing the utility of magnetic resonance imaging-based "SuStaIn" disease subtyping for precision medicine in relapsing-remitting and secondary progressive multiple sclerosisXiaotong Jiang, Changyu Shen, Bastien Caba, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|May 16, 2019
Breaking the cycle: Reversal of flux in the tricarboxylic acid cycle by dimethyl fumarateArie R Gafson, Constantinos Savva, Tom Thorne, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 6, 2021
A randomized study of natalizumab dosing regimens for relapsing-remitting multiple sclerosisMaria Trojano, Lluís Ramió-Torrentà, Luigi Me Grimaldi, et al.
CNS Drugs|July 29, 2021
Safety, Patient-Reported Well-Being, and Physician-Reported Assessment of Walking Ability in Patients with Multiple Sclerosis for Prolonged-Release Fampridine Treatment in Routine Clinical Practice: Results of the LIBERATE StudyGiovanni Castelnovo, Oliver Gerlach, Mark S Freedman, et al.
Pageof 2